[Federal Register: March 24, 2003 (Volume 68, Number 56)]
[Rules and Regulations]
[Page 14134]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24mr03-3]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 530
[Docket No. 03N-0024]
New Animal Drugs; Phenylbutazone; Extralabel Animal Drug Use;
Order of Prohibition; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting a final
rule that appeared in the Federal Register of February 28, 2003 (68 FR
9528). The document issued an order prohibiting the extralabel use of
phenylbutazone animal and human drugs in female dairy cattle 20 months
of age or older. FDA is correcting the regulation listing the
prohibition by replacing ``Phenylbutazone'' with ``Phenylbutazone in
female dairy cattle 20 months of age or older.'' This correction is
being made so that the phenylbutazone listing accurately reflects the
agency's intent, which is reflected in the preamble to the final rule.
DATES: This rule is effective May 29, 2003.
FOR FURTHER INFORMATION CONTACT: Gloria J. Dunnavan, Center for
Veterinary Medicine (HFV-230), Food and Drug Administration, 7500
Standish Pl., Rockville, MD 20855, 301-827-1168, e-mail:
gdunnava@cvm.fda.gov.
SUPPLEMENTARY INFORMATION: In FR Doc. 03-4741, appearing on page 9528
in the Federal Register of Friday, February 28, 2003, the following
correction is made:
Sec. 530.41 [Corrected]
On page 9530, in the first column, in Sec. 530.41 Drugs prohibited
for extralabel use in animals, in paragraph (a)(12),
``Phenylbutazone.'' is corrected to read ``Phenylbutazone in female
dairy cattle 20 months of age or older.''
Dated: March 13, 2003.
Stephen F. Sundlof,
Director, Center for Veterinary Medicine.
[FR Doc. 03-6891 Filed 3-21-03; 8:45 am]
BILLING CODE 4160-01-S